blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1523314

EP1523314 - PYRAZOLOPYRIMIDINES AS PROTEIN KINASE INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.07.2007
Database last updated on 05.10.2024
Most recent event   Tooltip07.07.2007Application deemed to be withdrawnpublished on 08.08.2007  [2007/32]
Applicant(s)For all designated states
SMITHKLINE BEECHAM CORPORATION
One Franklin Plaza
Philadelphia, PA 19101 / US
[N/P]
Former [2005/16]For all designated states
SmithKline Beecham Corporation
One Franklin Plaza
Philadelphia, PA 19101 / US
Inventor(s)01 / DICKERSON, Scott, Howard, c/o GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
02 / GARRIDO, Dulce, Maria, c/o GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
03 / MILLS, Wendy, Yoon, c/o GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
04 / KANO, Kazuya, c/o Tsukuba Research Laboratories
43 Wadai
Tsukuba-shi, Ibaraki Pref 300-4247 / JP
05 / PEAT, Andrew, James, c/o GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
06 / THOMSON, Stephen, Andrew, c/o GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
07 / WILSON, Jayme, Lyn, Roark, c/o GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
08 / ZHOU, Huiqiang, c/o GlaxoSmithKline
Five Moore Drive, PO Box 13398
Research Triangle Park, NC 27709 / US
 [2005/16]
Representative(s)Learoyd, Stephanie Anne
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2005/16]Learoyd, Stephanie Anne
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date03765828.321.07.2003
[2005/16]
WO2003US22719
Priority number, dateUS20020397947P23.07.2002         Original published format: US 397947 P
[2005/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004009597
Date:29.01.2004
Language:EN
[2004/05]
Type: A2 Application without search report 
No.:EP1523314
Date:20.04.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 29.01.2004 takes the place of the publication of the European patent application.
[2005/16]
Search report(s)International search report - published on:EP27.05.2004
ClassificationIPC:A61K31/505, C07D487/04, A61P3/00
[2005/16]
CPC:
C07D487/04 (EP,US); A61P15/00 (EP); A61P17/14 (EP);
A61P25/00 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P37/04 (EP); A61P43/00 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D401/04 (EP,US); C07D403/04 (EP,US);
C07D417/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/16]
Extension statesALNot yet paid
LT03.02.2005
LV03.02.2005
MKNot yet paid
TitleGerman:PYRAZOLOPYRIMIDINE ALS PROTEINKINASE-INHIBITOREN[2005/16]
English:PYRAZOLOPYRIMIDINES AS PROTEIN KINASE INHIBITORS[2005/16]
French:PYRAZOLOPYRIMIDINES EN TANT QU'INHIBITEURS DE KINASES[2005/16]
Entry into regional phase03.02.2005National basic fee paid 
03.02.2005Designation fee(s) paid 
03.02.2005Examination fee paid 
Examination procedure04.02.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
03.02.2005Amendment by applicant (claims and/or description)
03.02.2005Examination requested  [2005/16]
18.09.2006Despatch of a communication from the examining division (Time limit: M04)
31.01.2007Application deemed to be withdrawn, date of legal effect  [2007/32]
07.03.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2007/32]
Fees paidRenewal fee
08.07.2005Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.07.200604   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO0119829  (BASF AG [DE], et al) [A] 1-20,36-40 * page 1 - page 13; claim 1 *
 [X]  - BHAT ET AL., "Pyrazolopyrimidine Nucleosides. 12. Synthesis and Biological Activity of Certain Pyrazolo[3,4-d]pyrimidine Nucleosides Related to Adenosine", J. MED. CHEM., (1981), vol. 24, pages 1165 - 1172, XP002267111 [X] 1,10,11,16,36,37 * Cpds. 6, 14 *

DOI:   http://dx.doi.org/10.1021/jm00142a009
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.